Cardiovascular
Cardiovascular
Womens Health
Women's Health
two kidneys
Nephrology
Oncology
Oncology
Respiratory
Respiratory
Bayer for ProfessionalsYour Resource Portal
PP-PF-OTH-GB-0057 | February 2024

Welcome to BayerPRO

Latest resources
View more
NUBEQA®▼ (darolutamide) Resources
PP-NUB-GB-1699, July 2024
nmCRPC Patient Case Study
A Pharmacist Perspective - NUBEQA®▼ (darolutamide)
PP-NUB-GB-1693, July 2024
nmCRPC Patient Case Study
A Urologist Perspective - NUBEQA®▼ (darolutamide)
PP-NUB-GB-1694, July 2024
nmCRPC Patient Case Study
An Oncologist Perspective - NUBEQA®▼ (darolutamide)
PP-NUB-GB-1692, July 2024
Events & webinars
View more
Expert Perspectives in CRC - video series 1 (UKOF)
Stivarga® (regorafenib)
PP-STI-GB-0398, July 2024
Expert Perspectives in CRC - video series 2 (ESMO-GI)
Stivarga® (regorafenib)
PP-STI-GB-0399, July 2024
Frontiers at St Mark’s 2023
Stivarga® (regorafenib)
PP-STI-GB-0397, July 2024
Empowering Nurses for Colorectal Cancer Care
Stivarga® (regorafenib)
PP-STI-GB-0396, July 2024
Learning Zone
View more
Module 4:
Motivational Interviewing
RP-XAR-GB-5165, February 2024
Module 3
Motivational Interviewing CPD accredited course
RP-XAR-GB-5164, February 2024
Module 2:
Motivational Interviewing CPD accredited course
RP-XAR-GB-5163, February 2024
Module 1:
Motivational Interviewing CPD accredited course
RP-XAR-GB-5162, February 2024
Podcasts
View more
Current treatment landscape and the future for treating mCRC
Stivarga® (regorafenib)
PP-STI-GB-0201, February 2024
Episode 3
The Practicalities of Treatment — Xofigo®▼ (radium-223 dichloride)
PP-XOF-GB-0464, February 2024
Episode 1
Why treat with Xofigo®▼ (radium-223 dichloride)?
PP-XOF-GB-0462, February 2024
Episode 2
Optimising patient identification and referral — Xofigo®▼ (radium-223 dichloride)
PP-XOF-GB-0463, February 2024
Products
View more
NUBEQA®▼ (darolutamide)
In nmCRPC and mHSPC
PP-NUB-GB-1317, February 2024
Stivarga® (regorafenib)
In mCRC
PP-STI-GB-0204, February 2024
Nexavar® (sorafenib) & Stivarga® (regorafenib)
In HCC
PP-NEX-GB-0211, February 2024
Xofigo®▼ (radium-223 dichloride)
In mCRPC
PP-XOF-GB-0564, May 2024
Register with BayerPRO

To access additional resources, personalise your experience and keep up to date via electronic communications from Bayer.

 

Areas of Interest
Cardiovascular
Women's Health
Nephrology
Oncology
Respiratory